What makes BPC-157 distinctive among research peptides is a combination of three properties rarely found together: it has no sequence homology to any other known peptide, it is completely stable in human gastric acid for at least 24 hours (unlike most growth factors and peptide analogues, which are rapidly degraded), and it remains active across an exceptionally broad effective dose range from nanogram to microgram per kilogram bodyweight in pre-clinical models without any known toxic dose having been established in animal studies to date
Importantly, Carl knows how military prosecutors think and act because he used to be one
This led us to a debate about how, when you know a bit more about B12 deficiency and Pernicious Anaemia than your GP surgery, it comes as a bit of a surprise when bureaucracy outweighs common sense
That said, TB-500 as sold for research is a fragment, and data specific to the fragment rather than the full protein remain limited and largely preclinical
Each has its unique advantages, and your choice depends on what you aim to achieve